Skip to main content

Advertisement

ADVERTISEMENT

SmartTrak x Wound Care Collaboration News

News
10/09/2024
Kerecis announced the publication of the 255-patient Odinn study on grade 2 and 3 DFUs utilizing Marigen (intact fish skin graft). The study found healing was achieved in 44% of patients at 16 weeks vs 26% for SoC, with additional healing at...
Kerecis announced the publication of the 255-patient Odinn study on grade 2 and 3 DFUs utilizing Marigen (intact fish skin graft). The study found healing was achieved in 44% of patients at 16 weeks vs 26% for SoC, with additional healing at...
Kerecis announced the...
10/09/2024
Wound Care
News
10/09/2024
FeelTect generated significant interest by showcasing its TightAlright compression therapy sensor tool. The device monitors the level of compression at three points on the leg and facilitates the patient or caregiver to adjust the bandaging....
FeelTect generated significant interest by showcasing its TightAlright compression therapy sensor tool. The device monitors the level of compression at three points on the leg and facilitates the patient or caregiver to adjust the bandaging....
FeelTect generated significant...
10/09/2024
Wound Care
News
10/09/2024
Spectral Al announces the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area (TBSA) of a burn. This technology is currently integrated into the DeepView System for burn...
Spectral Al announces the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area (TBSA) of a burn. This technology is currently integrated into the DeepView System for burn...
Spectral Al announces the...
10/09/2024
Wound Care

Advertisement

News
10/09/2024
HidraMed launched HidraWear Foam Dressing, which combines the benefit of their SecureLock technology with the comfort of a foam dressing. The dressing is designed for moderately exuding wounds.
HidraMed launched HidraWear Foam Dressing, which combines the benefit of their SecureLock technology with the comfort of a foam dressing. The dressing is designed for moderately exuding wounds.
HidraMed launched HidraWear Foam...
10/09/2024
Wound Care
News
10/09/2024
A retrospective study of 218 breast reconstruction patients found that the ciNPWT group had no infections compared to a 10.4% infection rate in the non-intervention group after an average 2.2-year follow-up. The ciNPWT also showed lower...
A retrospective study of 218 breast reconstruction patients found that the ciNPWT group had no infections compared to a 10.4% infection rate in the non-intervention group after an average 2.2-year follow-up. The ciNPWT also showed lower...
A retrospective study of 218...
10/09/2024
Wound Care
News
10/09/2024
BioStem Technologies announces the initiation of the BR-AC-DFU-101 clinical trial to evaluate BR-AC (AmnioWrap 2) vs SoC for non-healing DFUs. The study will be conducted at 10 sites across the US with an expected completion date of the end...
BioStem Technologies announces the initiation of the BR-AC-DFU-101 clinical trial to evaluate BR-AC (AmnioWrap 2) vs SoC for non-healing DFUs. The study will be conducted at 10 sites across the US with an expected completion date of the end...
BioStem Technologies announces...
10/09/2024
Wound Care

Advertisement

News
10/09/2024
Organogenesis announces the publication of 218-patient RCT results demonstrating the safety and efficacy of NuShield for DFUs. The company believes the study satisfies Medicare coverage requirements under the proposed Local Coverage...
Organogenesis announces the publication of 218-patient RCT results demonstrating the safety and efficacy of NuShield for DFUs. The company believes the study satisfies Medicare coverage requirements under the proposed Local Coverage...
Organogenesis announces the...
10/09/2024
Wound Care
News
10/08/2024
A 170-patient RCT will assess the efficacy of PCMP (PuraPly AM) and SoC vs SoC alone for treatment of chronic DFUs with primary outcome of percentage of ulcer closure at 12 weeks. Recruitement is ongoing with estimated study completion in Nov...
A 170-patient RCT will assess the efficacy of PCMP (PuraPly AM) and SoC vs SoC alone for treatment of chronic DFUs with primary outcome of percentage of ulcer closure at 12 weeks. Recruitement is ongoing with estimated study completion in Nov...
A 170-patient RCT will assess...
10/08/2024
Wound Care
News
10/01/2024
A 200-patient RCT will evaluate the role of local 4-aminopyridine (4-AP) on the treatment of burn wounds to accelerate healing with primary outcome of healing rate up to 12 months. Not yet recruiting; estimated study completion is Sept 2028....
A 200-patient RCT will evaluate the role of local 4-aminopyridine (4-AP) on the treatment of burn wounds to accelerate healing with primary outcome of healing rate up to 12 months. Not yet recruiting; estimated study completion is Sept 2028....
A 200-patient RCT will evaluate...
10/01/2024
Wound Care

Advertisement

News
10/01/2024
A study of 80 nondiabetic laparotomy patients compared those who were treated with NPWT vs conventional dressing and found that the overall occurrence of SSIs within the 30-day follow-up period was significantly lower in the NPWT group, but...
A study of 80 nondiabetic laparotomy patients compared those who were treated with NPWT vs conventional dressing and found that the overall occurrence of SSIs within the 30-day follow-up period was significantly lower in the NPWT group, but...
A study of 80 nondiabetic...
10/01/2024
Wound Care

Advertisement